Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb615fde1c12b674c4c7bcf151900022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6728c93a6733cd2382cd1c1a13cccc7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_134aaa322d94889185d1365c3ead7409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d241434dd2e686fcc5aab7061164f8c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
filingDate |
2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0395a7b1bc3679a091f7261c89a4941 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150f5689b36f2c1cb8df39e9cf2ad16d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a697ce9c4c081aabb217b1402798fc15 |
publicationDate |
2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006128179-A2 |
titleOfInvention |
Use of matrilin-1 for the treatment of angiogenesis related diseases |
abstract |
The present invention is based on the discovery that Matrilin-1 has antiangiogenic and anticancer properties. The invention is directed to a method of treating a disease that responds to an inhibition of angiogenesis. Additionally, the invention can be applied to those at risk for developing a disease that responds to an inhibition of angiogenesis. The methods comprise administering to a mammal an effective angiogenesis-inhibiting amount of an Matrilin-1 consisting of Matrilin-1, Matrilin-1 fragment, analog, or derivative that is administered in a composition substantially free of other cartilage proteins. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009143367-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009143367-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089522-B2 |
priorityDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |